Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China An Observational Study to Investigate the Compliance of Home Nebulizer Therapy Among Children Aged 0-14 Years Old Clinically Diagnosed With Asthma

NCT03156998 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03156998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03156998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in China An Observational Study to Investigate the Compliance of Home Nebulizer Therapy Among Children Aged 0-14 Years Old Clinically Diagnosed With Asthma
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 25, 2017
Completion date
May 9, 2018
Enrollment
512 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

paediatric asthma